ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

Sanding Study Section For Cancer Control Grants Needed, Board Says

May 17, 1985

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982